Searched for
MODERNA INC.
Moderna stocks: MRNA shares jump in US Stock market today after pharma giant surpasses Wall Street estimatesModerna had earlier posted a loss of $2.52 per share a year earlier, while analysts expected a loss of $3.96 per share.- Moderna open to supplying COVID vaccines to China, CEO says"We are open, we have the capacity" Bancel said about supplying its mRNA-based shots to the country, declining to say whether Moderna had s...
- Moderna can make vaccine for Omicron by early next year“We should know about the ability of the current vaccine to provide protection in the next couple of weeks,” Burton said.
- Moderna says its COVID-19 vaccine protective, safe in young childrenModerna Inc said on Monday that its COVID-19 vaccine generated an immune response and was generally well-tolerated in children aged six to ...
- Moderna seeks COVID-19 vaccine booster clearance in older adults, high-risk individualsModerna's comments were released in briefing documents ahead of a Thursday meeting of the FDA's outside expert advisers to discuss the boos...
- Moderna working on booster to combine COVID-19 vaccine with a flu shotFlu shots cost around $18 to $25 a dose, according to U.S. government data and competition has kept price increases in check, with producer...
- Pfizer and Moderna raise prices for their COVID-19 vaccines in EU- FTThe new price for the Pfizer shot was 19.50 euros ($23.15)against 15.50 euros previously, the newspaper said citing to the portions of the ...
- Moderna files for full US approval of COVID-19 vaccineThe development comes weeks after rival Pfizer Inc and its German partner BioNTech SE sought full approval for their COVID-19 vaccine in th...
- Moderna raises 2021 sales forecast for COVID-19 vaccine to $19.2 billionEarlier this week, larger rival Pfizer Inc said it expects $26 billion in sales of its COVID-19 vaccine this year.
- Moderna boosting COVID-19 vaccine-making capacity, targets up to 3 billion shots in 2022"As we look forward to next year, we just see so much need for primary vaccine, we are hearing it all over the world, and also boosters," M...
- Are vaccines variant-proof? Here’s some good newsModerna Inc. has also noted, though not published data, that its new mRNA-1273.351 vaccine was able to boost the immune response of previou...
- AstraZeneca has sold its stake in Moderna for more than $1 billion: The TimesAstraZeneca is retaining partnership with Moderna on other disease treatments and could sell its AstraZeneca/Oxford University COVID-19 vac...
- Moderna's COVID-19 vaccine shots leave warehouses, widening America's push to immunizeThe distribution of Moderna's vaccine to more than 3,700 locations in the United States will vastly widen the rollout started last week by ...
- Trump, ahead of FDA, says Moderna's COVID-19 vaccine has been approvedThe FDA had not yet authorized emergency use of the vaccine, a Bloomberg reporter said on Twitter, citing the agency. FDA and Moderna did n...
- Canada has deal to get Moderna COVID-19 vaccine within 48 hours of approvalModerna's vaccine is currently under review by Canada's drug regulator. The Pfizer/BioNTech vaccine received regulatory approval last week ...
- Moderna's COVID-19 vaccine clears first US FDA hurdleFDA staff said a two-dose regimen of Moderna's vaccine was highly effective in preventing confirmed cases of COVID-19. The comments were ma...
- Trump to meet COVID-19 vaccine makers, distributors next week: Stat NewsThe meeting would take place days ahead of reviews of vaccine candidates from Moderna Inc and Pfizer-BioNTech SE Inc by two separate panels...
- Moderna mania draws bitcoin comparisons while shorts bleedModerna jumped as much as 17% in New York Tuesday. The stock has surged about 73% and added more than $28 billion in market value over the ...
- Markets are already pricing a successful Moderna vaccine shotThe bar was raised for markets to rally following an announcement by Pfizer Inc. that its vaccine protected 90 per cent of Covid-19 cases i...
- Moderna extends lipids deal to boost COVID-19 vaccine outputModerna Inc has extended a deal to secure large volumes of the lipids used to produce its experimental COVID-19 vaccine in a bid to meet in...
Load More
